Eiko Lifesciences Ltd — Others, 29-07-2025: AGM/EGM

Eiko LifeSciences has released its Annual Report for FY25 and will hold its 48th Annual General Meeting on September 5th, 2025. The company reported strong financial performance, with consolidated revenue reaching ₹37.66 Cr. Standalone profit after tax nearly doubled to ₹1.74 Cr, driven by a 16.3% revenue growth to ₹32.49 Cr and a 71.9% increase in EBITDA. Strategic expansion into container logistics through EikoVivify Logistics and R&D in healthcare via Eiko Scientific Solutions LLP are key highlights. The company also seeks approval to raise its authorized share capital to ₹20 Cr and appoint Mr. Sumukh Vartak as Whole Time Director.